DRRX Durect Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: DRRX

Price (delayed)

$0.7957

Market cap

$24.7M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.05

Enterprise value

$17.04M

DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic ...

Highlights
The EPS is up by 32% year-on-year and by 31% since the previous quarter
The net income has grown by 25% from the previous quarter and by 22% YoY
Durect's equity has decreased by 41% YoY but it has increased by 2.6% from the previous quarter
The company's quick ratio fell by 17% YoY but it rose by 6% QoQ
Durect's gross profit has shrunk by 61% YoY and by 10% QoQ
The revenue has dropped by 56% year-on-year and by 7% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.durect.com/
Peers: JNJ PCRX PFE LLY

Key stats

What are the main financial stats of DRRX
Market
Shares outstanding
31.04M
Market cap
$24.7M
Enterprise value
$17.04M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.61
Price to sales (P/S)
2.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.99
Earnings
Revenue
$8.55M
EBIT
-$24.83M
EBITDA
-$24.8M
Free cash flow
-$34.38M
Per share
EPS
-$1.05
Free cash flow per share
-$1.31
Book value per share
$0.5
Revenue per share
$0.33
TBVPS
$1.49
Balance sheet
Total assets
$45.19M
Total liabilities
$30.41M
Debt
$20.75M
Equity
$14.78M
Working capital
$7.66M
Liquidity
Debt to equity
1.4
Current ratio
1.28
Quick ratio
1.15
Net debt/EBITDA
0.31
Margins
EBITDA margin
-290.1%
Gross margin
79.9%
Net margin
-323.2%
Operating margin
-431.5%
Efficiency
Return on assets
-53.4%
Return on equity
-220.9%
Return on invested capital
N/A
Return on capital employed
-136.6%
Return on sales
-290.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DRRX stock price

How has the Durect stock price performed over time
Intraday
0%
1 week
-5.83%
1 month
-38.32%
1 year
-82.4%
YTD
34.86%
QTD
-34.24%

Financial performance

How have Durect's revenue and profit performed over time
Revenue
$8.55M
Gross profit
$6.83M
Operating income
-$36.88M
Net income
-$27.62M
Gross margin
79.9%
Net margin
-323.2%
DRRX's operating margin has shrunk by 137% YoY but it is up by 6% QoQ
The net margin has dropped by 76% year-on-year but it is up by 19% since the previous quarter
Durect's gross profit has shrunk by 61% YoY and by 10% QoQ
The revenue has dropped by 56% year-on-year and by 7% since the previous quarter

Growth

What is Durect's growth rate over time

Valuation

What is Durect stock price valuation
P/E
N/A
P/B
1.61
P/S
2.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.99
The EPS is up by 32% year-on-year and by 31% since the previous quarter
DRRX's P/B is 83% below its 5-year quarterly average of 9.2 and 82% below its last 4 quarters average of 8.8
Durect's equity has decreased by 41% YoY but it has increased by 2.6% from the previous quarter
The price to sales (P/S) is 82% lower than the 5-year quarterly average of 13.5 and 53% lower than the last 4 quarters average of 5.2
The revenue has dropped by 56% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Durect business performance
Durect's ROE has plunged by 125% YoY but it has increased by 9% from the previous quarter
The ROS has dropped by 70% year-on-year but it is up by 21% since the previous quarter
Durect's ROA has increased by 19% from the previous quarter but it has decreased by 6% YoY

Dividends

What is DRRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DRRX.

Financial health

How did Durect financials performed over time
The total assets is 49% more than the total liabilities
DRRX's total liabilities is down by 25% QoQ and by 13% YoY
The total assets has contracted by 25% YoY and by 17% from the previous quarter
The debt is 40% greater than the equity
The debt to equity has soared by 51% year-on-year but it is down by 13% since the previous quarter
Durect's equity has decreased by 41% YoY but it has increased by 2.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.